Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 2/20 | 0.67 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.53 |
| ▸ | HTR2A | P28223 | 6/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30136435 | 1.00 | HMGCR (0.67) | HMGCRTAAR1CYP19A1HTR2ACYP3A4 | |
| SCHEMBL28748249 | 1.00 | HMGCR (0.67) | HMGCRTAAR1CYP19A1HTR2ACYP3A4 | |
| SCHEMBL23222349 | 0.90 | HMGCR (0.72) | HMGCRTAAR1CYP19A1HTR2ACYP3A4 | |
| SCHEMBL12892627 | 0.88 | TAAR1 (0.70) | HMGCRTAAR1HTR2ACYP3A4HTR2C | |
| SCHEMBL29376427 | 0.85 | TAAR1 (0.78) | TAAR1HTR2AHTR2C | |
| SCHEMBL23424386 | 0.85 | TAAR1 (0.69) | HMGCRTAAR1HTR2AHTR2C | |
| SCHEMBL2562751 | 0.85 | TAAR1 (0.78) | TAAR1HTR2AHTR2C | |
| SCHEMBL12250880 | 0.84 | HMGCR (0.64) | HMGCRTAAR1HTR2ACYP3A4 | |
| Butyric Acid SCHEMBL28877004 | 0.84 | HMGCR (0.59) | HMGCRTAAR1CYP19A1CYP3A4 | |
| SCHEMBL11793593 | 0.83 | HMGCR (0.81) | HMGCRTAAR1HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6969778-B2 | DDQ mediated one step dimerization of β-asarone or β-asarone rich Acorus calamus oil in the formation of novel neolignan | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2005-11-29 | — | — | US | claimed |
| WO-2003082786-A1 | A PROCESS FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE ALPHA-ASARONE FROM TOXIC BETA-ASARONE RICH ACORUS CALAMUS OIL | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-10-09 | — | — | WO | claimed |
| US-6590127-B1 | Formation of alpha-asarone, isoacoramone and 2,4,5-trimethoxycinnamaldehyde in one step process via 2,3-dichloro-5,6-dicyano-1,4-benzoquinone assisted dehydrogenation/oxidation of 2,4,5-trimethoxyphenylpropane | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2003-07-08 | — | — | US | claimed |
| US-20030113275-A1 | Process for the preparation of 1-Propyl-2, 4, 5- trimethoxybenzene from toxic beta-asarone of Acorus calamus or from crude calamus oil containing beta-asarone | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2003-06-19 | — | — | US | claimed |
| US-20020035299-A1 | Process for the preparation of 1-Propyl-2, 4, 5-trimethoxybenzene from toxic beta-asarone of acorus calamus or from crude calamus oil containing beta-asarone | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2002-03-21 | — | — | US | claimed |
| EP-4011921-B1 | RUBBER WITH BACKBONE AND END-GROUP FUNCTIONALIZATION AND ITS METHOD OF MANUFACTURING AND USE IN A TIRE | G 3 CHICKADEE PURCHASER LLC 1485 E ARCHWOOD AVENUE (US) | 2026-02-04 | — | — | EP | disclosed |
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | disclosed |
| CN-114621375-B | Rubber with backbone and end-group functionalization | 固特异轮胎和橡胶公司 | 2024-06-18 | — | — | CN | disclosed |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-05-30 | — | — | US | disclosed |
| EP-3310893-B2 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2024-02-28 | — | — | EP | disclosed |
| US-11912798-B2 | Rubber with backbone and end-group functionalization | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2024-02-27 | — | — | US | disclosed |
| US-20230312798-A1 | FUNCTIONALIZED HYDROGENATED POLYMERS | MIZUHO BANK, LTD., AS ADMINISTRATIVE AGENT | 2023-10-05 | — | — | US | disclosed |
| EP-0438967-B1 | Segmented elastomer | GOODYEAR TIRE & RUBBER (US) | 1996-05-01 | — | — | EP | disclosed |
| US-5239009-A | Butadiene, isoprene, styrene random polymer, wear resistance, good traction tire treads | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1993-08-24 | — | — | US | disclosed |
| US-5202387-A | Modified styrene-butadiene copolymer; catalytic polymerization using living-catalyst | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1993-04-13 | — | — | US | disclosed |
| US-5100965-A | Process for synthesizing high trans polymers | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1992-03-31 | — | — | US | disclosed |
| US-5070148-A | SEGMENTED ELASTOMER | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1991-12-03 | — | — | US | disclosed |
| EP-0438967-A1 | Segmented elastomer | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1991-07-31 | — | — | EP | disclosed |
| EP-0258167-A2 | Modifier for lithium catalysts | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1988-03-02 | — | — | EP | disclosed |
| US-4696986-A | 1,2,3- OR 1,2,4-TRIALKOXYBENZENE MODIFIERS | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1987-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035299-A1 | Process for the preparation of 1-Propyl-2, 4, 5-trimethoxybenzene from toxic beta-asarone of acorus calamus or from crude calamus oil containing beta-asarone | ADRA2B, CYP1B1, ADRB1 | HMGCR 365/4885TAAR1 135/4885CYP19A1 71/4885 |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | FABP2, FABP5, FAAH2 | HMGCR 1696/4885TAAR1 1192/4885CYP19A1 167/4885 |
| US-20030113275-A1 | Process for the preparation of 1-Propyl-2, 4, 5- trimethoxybenzene from toxic beta-asarone of Acorus calamus or from crude calamus oil containing beta-asarone | ADRA2B, CYP1B1, ADRB1 | HMGCR 348/4885TAAR1 140/4885CYP19A1 72/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.